Closed System Transfer Device (CSTD) Market
Closed System Transfer Device CSTD is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Now some companies see the future profit, they started to expand their investment on Closed System Transfer Device CSTD to occupy the market share. For Example, Equashield, a leading provider of Closed System Transfer Devices CSTDs for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. The company will invest an estimated $30 million to build the new plant to meet the growing market demand for manual and automated hazardous drug compounding devices.
Corvida Medical has leveraged about $6 million in non-dilutive federal, state, and private awards and secured $2.25 million in Series A proceeds to achieve critical milestones to date. Corvida completed a $10.9 million Series B over a series of tranches with the final closing in mid-2015 and is now seeking a convertible note investment, with $3.8 million already committed and on track to close Q1 2016. Management anticipates a $7-10 million Series C late 2016/early 2017 including the convertible note proceeds with funds to be used to scale-up manufacturing capacity, build-out production inventory, add personnel, and fuel revenue growth. Corvida has an opportunity to achieve cash flow positive within 2 years of launch on roughly $1 million in monthly sales, and a realistic opportunity to ramp revenues to $20-30 million within 2-3 years! Meanwhile, the government s attitude has a huge impact on the market. However, now, only the United States and some European and Asia countries have promulgated relevant policies. But, even in these countries, the level of promotion is still relatively low.
Request a Sample Copy of Report @ https://www.planetmarketreports.com/report-sample/global-closed-system-transfer-device-cstd-market-growth-2019-2024
USA dominated the Closed System Transfer Device CSTD and is the largest production base. In addition to the USA, there are some other production areas, such as Europe. In the consumption market, North America is the main consumption regions due to the bigger demand for downstream applications. In 2017, North America occupied 89.37% of the global consumption value in total. But the above forecast is based on the current policy. If a country suddenly made the relevant policies, then the entire market will change.
According to this study, over the next five years, the Closed System Transfer Device CSTD market will register a 21.3% CAGR in terms of revenue, the global market size will reach US$ 1469.3 million by 2024, from US$ 560.3 million in 2019. In particular, this report presents the global market share sales and revenue of key companies in the Closed System Transfer Device CSTD business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Closed System Transfer Device CSTD market by product type, application, key manufacturers and key regions and countries.
This study considers the Closed System Transfer Device CSTD value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
America
APAC
Europe
Middle East & Africa
Rest of the World
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Get Detailed Information about this Research Report @ https://www.planetmarketreports.com/reports/global-closed-system-transfer-device-cstd-market-growth-2019-2024
Research objectives
To study and analyze the global Closed System Transfer Device CSTD consumption value & volume by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of the Closed System Transfer Device CSTD market by identifying its various subsegments.
Focuses on the key global Closed System Transfer Device CSTD manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in next few years.
To analyze the Closed System Transfer Device CSTD with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industry-specific challenges and risks.
To project the consumption of Closed System Transfer Device CSTD submarkets, with respect to key regions along with their respective key countries.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Our analysts can customize this market research report to meet your requirements.
Contact Info:
Name: Jennifer Daniel
Email-Id: sales@planetmarketreports.com
US: +1-716-2260907
UK: +447441952057
Organization: Planet Market Reports